Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease blood.

Lunnon K, Ibrahim Z, Proitsi P, Lourdusamy A, Newhouse S, Sattlecker M, Furney S, Saleem M, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Coppola G, Geschwind D, Simmons A, Lovestone S, Dobson R, Hodges A; AddNeuroMed Consortium.

J Alzheimers Dis. 2012;30(3):685-710. doi: 10.3233/JAD-2012-111592.

PMID:
22466004
2.

Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease.

Berchtold NC, Sabbagh MN, Beach TG, Kim RC, Cribbs DH, Cotman CW.

Neurobiol Aging. 2014 Sep;35(9):1961-72. doi: 10.1016/j.neurobiolaging.2014.03.031. Epub 2014 Apr 2.

3.

Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease.

Lueg G, Gross CC, Lohmann H, Johnen A, Kemmling A, Deppe M, Groger J, Minnerup J, Wiendl H, Meuth SG, Duning T.

Neurobiol Aging. 2015 Jan;36(1):81-9. doi: 10.1016/j.neurobiolaging.2014.08.008. Epub 2014 Aug 23.

PMID:
25277040
5.

Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in blood.

Proitsi P, Lee SH, Lunnon K, Keohane A, Powell J, Troakes C, Al-Sarraj S, Furney S, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Hodges A; AddNeuroMed Consortium.

Neurobiol Aging. 2014 Feb;35(2):279-90. doi: 10.1016/j.neurobiolaging.2013.08.002. Epub 2013 Sep 21.

PMID:
24064185
6.

Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's disease: a pilot study.

Movérare-Skrtic S, Johansson P, Mattsson N, Hansson O, Wallin A, Johansson JO, Zetterberg H, Blennow K, Svensson J.

Exp Gerontol. 2012 Feb;47(2):179-82. doi: 10.1016/j.exger.2011.12.005. Epub 2011 Dec 22.

PMID:
22210159
7.

Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease.

Torres LL, Quaglio NB, de Souza GT, Garcia RT, Dati LM, Moreira WL, Loureiro AP, de Souza-Talarico JN, Smid J, Porto CS, Bottino CM, Nitrini R, Barros SB, Camarini R, Marcourakis T.

J Alzheimers Dis. 2011;26(1):59-68. doi: 10.3233/JAD-2011-110284.

PMID:
21593563
8.

Increased expression of interleukin-18 receptor in blood cells of subjects with mild cognitive impairment and Alzheimer's disease.

Salani F, Ciaramella A, Bizzoni F, Assogna F, Caltagirone C, Spalletta G, Bossù P.

Cytokine. 2013 Feb;61(2):360-3. doi: 10.1016/j.cyto.2012.11.001. Epub 2012 Nov 30.

PMID:
23201485
9.

Peripheral mitochondrial dysfunction in Alzheimer's disease: focus on lymphocytes.

Leuner K, Schulz K, Schütt T, Pantel J, Prvulovic D, Rhein V, Savaskan E, Czech C, Eckert A, Müller WE.

Mol Neurobiol. 2012 Aug;46(1):194-204. doi: 10.1007/s12035-012-8300-y. Epub 2012 Jul 22. Review.

PMID:
22821186
10.

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.

Hampel H, Bürger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K.

Alzheimers Dement. 2008 Jan;4(1):38-48. doi: 10.1016/j.jalz.2007.08.006. Epub 2007 Dec 21. Review.

PMID:
18631949
11.

Unfolded p53 in blood as a predictive signature signature of the transition from mild cognitive impairment to Alzheimer's disease.

Lanni C, Racchi M, Stanga S, Mazzini G, Ranzenigo A, Polotti R, Memo M, Govoni S, Uberti D.

J Alzheimers Dis. 2010;20(1):97-104. doi: 10.3233/JAD-2010-1347.

PMID:
20164600
12.

MRI and CSF studies in the early diagnosis of Alzheimer's disease.

de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S, Clark C, Kerkman D, DeBernardis J, Li J, Lair L, Reisberg B, Tsui W, Rusinek H.

J Intern Med. 2004 Sep;256(3):205-23.

13.

Gene expression profiling of peripheral blood leukocytes identifies and validates ABCB1 as a novel biomarker for Alzheimer's disease.

Chen KD, Chang PT, Ping YH, Lee HC, Yeh CW, Wang PN.

Neurobiol Dis. 2011 Sep;43(3):698-705. doi: 10.1016/j.nbd.2011.05.023. Epub 2011 Jun 6.

PMID:
21669286
14.

Delayed rather than decreased BOLD response as a marker for early Alzheimer's disease.

Rombouts SA, Goekoop R, Stam CJ, Barkhof F, Scheltens P.

Neuroimage. 2005 Jul 15;26(4):1078-85. Epub 2005 Apr 26.

PMID:
15961047
15.

Peripheral inflammatory cytokines as biomarkers in Alzheimer's disease and mild cognitive impairment.

Guerreiro RJ, Santana I, Brás JM, Santiago B, Paiva A, Oliveira C.

Neurodegener Dis. 2007;4(6):406-12. Epub 2007 Oct 9.

PMID:
17934323
16.

Association between brain-derived neurotrophic factor (BDNF) gene polymorphisms and executive function in Japanese patients with Alzheimer's disease.

Nagata T, Shinagawa S, Nukariya K, Ochiai Y, Kawamura S, Agawa-Ohta M, Kasahara H, Nakayama K, Yamada H.

Psychogeriatrics. 2011 Sep;11(3):141-9. doi: 10.1111/j.1479-8301.2011.00364.x. Epub 2011 Jun 15.

PMID:
21951954
17.

Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: a pilot-study.

Marksteiner J, Imarhiagbe D, Defrancesco M, Deisenhammer EA, Kemmler G, Humpel C.

Exp Gerontol. 2014 Feb;50:114-21. doi: 10.1016/j.exger.2013.12.001. Epub 2013 Dec 10.

18.

Progression from amnesic mild cognitive impairment to Alzheimer's disease: ESR1 and ESR2 polymorphisms and APOE gene.

Elcoroaristizabal Martín X, Fernández Martínez M, Galdos Alcelay L, Molano Salazar A, Bereincua Gandarias R, Inglés Borda S, Gómez Busto F, Uterga Valiente JM, Indakoetxea Juanbeltz B, Gómez Beldarraín MA, de Pancorbo MM.

Dement Geriatr Cogn Disord. 2011;32(5):332-41. doi: 10.1159/000335541. Epub 2012 Feb 3.

PMID:
22311091
19.

Characteristic transformation of blood transcriptome in Alzheimer's disease.

Han G, Wang J, Zeng F, Feng X, Yu J, Cao HY, Yi X, Zhou H, Jin LW, Duan Y, Wang YJ, Lei H.

J Alzheimers Dis. 2013;35(2):373-86. doi: 10.3233/JAD-121963.

PMID:
23411692
20.

Searching for predictive blood biomarkers: misfolded p53 in mild cognitive impairment.

Stanga S, Lanni C, Sinforiani E, Mazzini G, Racchi M.

Curr Alzheimer Res. 2012 Dec;9(10):1191-7.

PMID:
22746246
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk